Delivery Order W81XWH22D0016-HT942523F0157
Award Date 6/5/23
Potential Completion Date 11/30/23
Potential Value $68K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Woburn, MA 01801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded Creagen Inc., an SBA-certified 8(a) small business, a $37,209.60 firm fixed price delivery order for small molecule synthesis task order 01 in support of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) program. The place of performance is Woburn, Massachusetts and work is to be completed by May 12, 2023. No set-aside designation was used for this award issued against an unspecified multiple award contract vehicle. Creagen Inc. will...
- The U.S. National Institute of Child Health and Human Development (NIDDK) awarded a $94,400.00 Firm Fixed Price purchase order contract to Creagen Inc., a small, minority-owned business located in Woburn, Massachusetts. The contract is for the synthesis of chemical compounds, which will support NIDDK's medical research programs. Creagen Inc. is an SBA Certified 8(a) Program Participant and a self-certified small disadvantaged business. The company has significant experience providing specialized...
- This is a Firm Fixed Price contract awarded by the Department of the Army Medical Command to Creare LLC, doing business as Creare, under the SBIR (Small Business Innovation Research) Program Phase I. The contract has a potential value of $149,936.28 and is set aside for small businesses. Creare is an engineering research and development company that provides innovative solutions to complex technology challenges for government and industry clients, with extensive experience supporting U.S....
- This is a $207,594.08 firm fixed-price purchase order awarded to Creare LLC, doing business as Creare, by the Defense Health Agency. The contract, which is not set aside, is for labor under Task 1 of a Research, Development, Test and Evaluation (RDT&E) effort. Creare is an engineering research and development company that specializes in advanced technologies for government and industry customers. The contract has an ultimate completion date of September 25, 2025 and is part of the Small...
- This is a $1,849,894.22 firm fixed price contract awarded by the Medical Command, a Defense agency, to Creare LLC for an SBIR Phase I research project. The contract has a total small business set-aside designation. Creare, an engineering research and development company, is the prime contractor. The contract's ultimate completion date is September 30, 2013. Creare has extensive experience delivering research, engineering, prototype development, testing, and manufacturing services to U.S. federal...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Creare LLC, a small business research and development company. The $162,430 firm-fixed-price contract has a period of performance through November 30, 2024. Creare is delivering research and development services related to the AWAAP (unspecified) program. The contract was awarded under a total small business set-aside. Creare also holds two larger...
- This is a 24-month Firm Fixed Price (FFP) contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Creare LLC, a small business, through the Small Business Innovation Research (SBIR) Phase II program. The $999,930.81 award is for research and development work related to the Army's mission objectives. Creare has extensive experience providing research, engineering, prototype development, and testing services to U.S. federal agencies across...
- This is a federal contract award to Creare LLC, doing business as Creare, for a Small Business Innovation Research (SBIR) Phase II effort. The contract, valued at $997,244.29, was awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) on December 10, 2018, with a final completion date of February 9, 2022. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract is set aside for small businesses and falls under the Coronavirus COVID-19...
- This is a $7,220,282.80 SBIR Phase III contract awarded by the Defense Health Agency to Creare LLC, a for-profit limited liability company that specializes in research, engineering, and niche manufacturing services for government and industry clients. The contract is a Cost Plus Fixed Fee definitive contract with no set-aside designation. Creare is leveraging its expertise in areas such as sensors, electronics, cryogenics, and advanced materials to develop innovative technologies under this SBIR...
- The Defense Health Agency awarded Chenega Professional & Technical Services LLC a $45.7M firm fixed-price definitive contract for scientific and technical research support services. This 8(a) sole source award, with an ultimate completion date of September 30, 2025, consolidates two previously separate research support requirements at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in Frederick, Maryland. The consolidation was designed to achieve operational...
- W81XWH22D0016Indefinite Delivery Contract
- W81XWH22D0016-HT942523F0157Delivery Order
The Defense Health Agency awarded Creagen Inc., an SBA Certified 8A Program Participant, a $68,217.60 firm fixed price delivery order against an unspecified multiple award contract vehicle. The order is for small molecule synthesis task order 02 in support of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) program. Work will be performed in Woburn, Massachusetts through November 30, 2023. No set aside designation was applied to this award. Creagen Inc. will provide synthetic chemistry services to USAMRIID, which conducts basic and applied research on biological defense against current and emerging infectious disease threats.
Generated 1/3/24, 4:42 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Small Molecule Synthesis in support of the U. S. Army Medical Research Institute of Infectious Diseases (USAMRIID) | W81XWH22R0084 | Department of the Army Medical Command | Solicitation 1/2 | 8/8/22, 11:42 AM | |
Small Molecule Synthesis in support of the U. S. Army Medical Research Institute of Infectious Diseases (USAMRIID) | W81XWH22D0016 | Department of the Army Medical Command | Award Notice 2/2 | 9/21/22, 11:29 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $68.2k | 6/5/23 |